Genetic Technologies Ltd (GENE) — Cash Flow Reinvestment Rate
Genetic Technologies Ltd (GENE) has a Cash Flow Reinvestment Rate of 0.06x as of June 2011, reinvesting $69.84K (capex $69.84K ) from operating cash flow of $1.12 Million. Check Genetic Technologies Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genetic Technologies Ltd Cash Flow Reinvestment Rate (2007–2011)
Historical reinvestment intensity for Genetic Technologies Ltd across 3 annual periods. Explore Genetic Technologies Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Genetic Technologies Ltd (2007–2011)
Year-by-year capital reinvestment analysis for Genetic Technologies Ltd. For live market cap and broader valuation context, see market cap of Genetic Technologies Ltd.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2011 | 0.06x | $139.68K | $2.23 Million | $139.68K | ▼ -77.6% |
| 2008 | 0.28x | $118.26K | $423.68K | $118.26K | ▲ +286.6% |
| 2007 | 0.07x | $158.87K | $2.20 Million | $158.87K | — |